Cardiovascular complications following pneumonia: focus on pneumococcus and heart failure

Benjamin Bartlett, Herbert P. Ludewick, Silvia Lee, Girish Dwivedi

Research output: Contribution to journalArticle

Abstract

PURPOSE OF REVIEW: Pneumonia, an inflammatory disease, is the single largest infectious cause of death. Pneumonia has recently been established as an important contributing factor to major adverse cardiovascular events including heart failure. Developing an intermechanistic understanding of pneumonia and cardiovascular disease is crucial for successful future drug therapy and reducing healthcare expenditure. RECENT FINDINGS: Up to 30% of patients admitted with pneumonia develop cardiovascular complications such as heart failure within 10 years of hospital discharge. Recent mechanistic studies have identified inflammation, pneumolysin, platelet activation, and thrombus formation at the center of cardiovascular disease progression. SUMMARY: In this review, we will detail current knowledge of the mechanistic interaction between pneumonia and development of cardiovascular disease as well as discuss the current and potential drug therapy targets.

Original languageEnglish
Pages (from-to)233-239
Number of pages7
JournalCurrent Opinion in Cardiology
Volume34
Issue number2
DOIs
Publication statusPublished - 1 Mar 2019

Fingerprint

Streptococcus pneumoniae
Pneumonia
Heart Failure
Cardiovascular Diseases
Drug Therapy
Platelet Activation
Health Expenditures
Disease Progression
Cause of Death
Thrombosis
Inflammation
Delivery of Health Care

Cite this

@article{f2b1fbbfb65949f0a7ed4e6e5dda4de0,
title = "Cardiovascular complications following pneumonia: focus on pneumococcus and heart failure",
abstract = "PURPOSE OF REVIEW: Pneumonia, an inflammatory disease, is the single largest infectious cause of death. Pneumonia has recently been established as an important contributing factor to major adverse cardiovascular events including heart failure. Developing an intermechanistic understanding of pneumonia and cardiovascular disease is crucial for successful future drug therapy and reducing healthcare expenditure. RECENT FINDINGS: Up to 30{\%} of patients admitted with pneumonia develop cardiovascular complications such as heart failure within 10 years of hospital discharge. Recent mechanistic studies have identified inflammation, pneumolysin, platelet activation, and thrombus formation at the center of cardiovascular disease progression. SUMMARY: In this review, we will detail current knowledge of the mechanistic interaction between pneumonia and development of cardiovascular disease as well as discuss the current and potential drug therapy targets.",
author = "Benjamin Bartlett and Ludewick, {Herbert P.} and Silvia Lee and Girish Dwivedi",
year = "2019",
month = "3",
day = "1",
doi = "10.1097/HCO.0000000000000604",
language = "English",
volume = "34",
pages = "233--239",
journal = "Current Opinion in Cardiology",
issn = "0268-4705",
publisher = "Lippincott Williams & Wilkins",
number = "2",

}

Cardiovascular complications following pneumonia : focus on pneumococcus and heart failure. / Bartlett, Benjamin; Ludewick, Herbert P.; Lee, Silvia; Dwivedi, Girish.

In: Current Opinion in Cardiology, Vol. 34, No. 2, 01.03.2019, p. 233-239.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cardiovascular complications following pneumonia

T2 - focus on pneumococcus and heart failure

AU - Bartlett, Benjamin

AU - Ludewick, Herbert P.

AU - Lee, Silvia

AU - Dwivedi, Girish

PY - 2019/3/1

Y1 - 2019/3/1

N2 - PURPOSE OF REVIEW: Pneumonia, an inflammatory disease, is the single largest infectious cause of death. Pneumonia has recently been established as an important contributing factor to major adverse cardiovascular events including heart failure. Developing an intermechanistic understanding of pneumonia and cardiovascular disease is crucial for successful future drug therapy and reducing healthcare expenditure. RECENT FINDINGS: Up to 30% of patients admitted with pneumonia develop cardiovascular complications such as heart failure within 10 years of hospital discharge. Recent mechanistic studies have identified inflammation, pneumolysin, platelet activation, and thrombus formation at the center of cardiovascular disease progression. SUMMARY: In this review, we will detail current knowledge of the mechanistic interaction between pneumonia and development of cardiovascular disease as well as discuss the current and potential drug therapy targets.

AB - PURPOSE OF REVIEW: Pneumonia, an inflammatory disease, is the single largest infectious cause of death. Pneumonia has recently been established as an important contributing factor to major adverse cardiovascular events including heart failure. Developing an intermechanistic understanding of pneumonia and cardiovascular disease is crucial for successful future drug therapy and reducing healthcare expenditure. RECENT FINDINGS: Up to 30% of patients admitted with pneumonia develop cardiovascular complications such as heart failure within 10 years of hospital discharge. Recent mechanistic studies have identified inflammation, pneumolysin, platelet activation, and thrombus formation at the center of cardiovascular disease progression. SUMMARY: In this review, we will detail current knowledge of the mechanistic interaction between pneumonia and development of cardiovascular disease as well as discuss the current and potential drug therapy targets.

UR - http://www.scopus.com/inward/record.url?scp=85061137274&partnerID=8YFLogxK

U2 - 10.1097/HCO.0000000000000604

DO - 10.1097/HCO.0000000000000604

M3 - Article

VL - 34

SP - 233

EP - 239

JO - Current Opinion in Cardiology

JF - Current Opinion in Cardiology

SN - 0268-4705

IS - 2

ER -